You can buy Hernexeos at the lowest price at Nextgen.ooo online pharmacy. Zongertinib is an orally bioavailable, selective tyrosine kinase inhibitor that irreversibly targets activating HER2 mutations, including exon 20 insertions, used to inhibit downstream oncogenic signaling in patients with HER2-mutant non-small cell lung cancer. Zongertinib is a selective, irreversible tyrosine kinase inhibitor that targets human epidermal growth factor receptor 2 (HER2). It covalently binds to the HER2 receptor, including exon 20 insertions, and inhibits downstream signaling pathways while sparing wild-type epidermal growth factor receptor (EGFR), which serves to limit associated toxicities.
 
On August 8, 2025, the US FDA granted accelerated approval to zongertinib for the treatment of advanced forms of non-small cell lung cancer (NSCLC) with HER2 tyrosine kinase domain activating mutations.